Breeders, Owners and Trainers! We want to hear from you to make sure we capture the full impact of Ontario’s horse racing industry. Complete OLG’s Post-Pandemic Economic Impact Survey before May 31st.  You could walk away with an amazing $1,600 prize package. 

Addition of Amlodipine, Ciclesonide and Methadone to the Schedule of Prohibited Drugs in the Pari-Mutuel Betting Supervision Regulations

Member Information > News & Racing Results > Industry News > 2020 > Addition of Amlodipine, Ciclesonide and Methadone to the Schedule of Prohibited Drugs in the Pari-Mu

Addition of Amlodipine, Ciclesonide and Methadone to the Schedule of Prohibited Drugs in the Pari-Mutuel Betting Supervision Regulations

November 2, 2020
By AGCO
Addition of Amlodipine, Ciclesonide and Methadone to the Schedule of Prohibited Drugs in the Pari-Mutuel Betting Supervision Regulations

In consultation with its Drug Advisory Committee, the Canadian Pari-Mutuel Agency (CPMA) has officially added the following drugs to section 1 of the Schedule to the Pari-Mutuel Betting Supervision RegulationsAmlodipine, Ciclesonide and Methadone.

  • Amlodipine is an approved veterinary drug used to reduce high blood pressure in cats. This drug is not recognized for use in horses.
  • Ciclesonide is an inhaled steroid used to treat breathing problems in horses caused by asthma. The CPMA intends to develop and publish an Elimination Guideline for ciclesonide.
  • Methadone is an opioid painkiller licensed for cats.

Any detection of the above drugs may result in a positive test.

The CPMA strongly recommends consulting a veterinarian on any decision to administer supplements or medications to a racehorse.

Testing for these drugs will begin on December 1, 2020.

More Industry News